17^th World Drug Delivery Summit

Business opportunities in drug delivery

The global market for drug delivery technology business development was US$131.6 billion in 2010 and is expected to grow at a compound annual growth rate (CAGR) of 5%, reaching nearly US$175.6 billion in 2016. The US accounted for about 59% of the total drug supply market in 2010 and reached US$78 billion. It is expected to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe accounted for about 27% of the total drug delivery market in 2010 and is worth US$36 billion. It is expected to grow to $49 billion in 2016, with a CAGR of 5.6% for 2013. The global drug delivery market stands at $150.3 billion, according to a BCC study. That's an increase from $142 billion last year. The market represents a significant business opportunity given the projected annual growth, which is reflected in the growing number of drug delivery specialists. Consistent product quality and competitive costs improve manufacturing performance and supply continuity, as well as product and technology audits and due diligence, minimizing regulatory, and quality control and business development issues.